Exercise Prescription for Patients with CHF (Read
... After viewing this presentation the physical therapist will be able to: ...
... After viewing this presentation the physical therapist will be able to: ...
Cardio-Pulmonary Resuscitation (CPR)
... Bicarbonate and calcium should not administered by endobronchial route. Epinephrine (adrenaline) is useful due to its alpha effect which increases the coronary and cerebral perfusions, though its beta effects by increasing the myocardial oxygen consumption can be potentially detrimental. The dose is ...
... Bicarbonate and calcium should not administered by endobronchial route. Epinephrine (adrenaline) is useful due to its alpha effect which increases the coronary and cerebral perfusions, though its beta effects by increasing the myocardial oxygen consumption can be potentially detrimental. The dose is ...
Different effect of exercise on left ventricular diastolic time and
... Background: In patients with idiopathic dilated cardiomyopathy (IDCM) a prolongation of left ventricular (LV) systole at the expense of diastolic time was demonstrated. Our study was aimed to evaluate the effect of exercise on heart rate corrected diastolic time in controls, IDCM with and without LB ...
... Background: In patients with idiopathic dilated cardiomyopathy (IDCM) a prolongation of left ventricular (LV) systole at the expense of diastolic time was demonstrated. Our study was aimed to evaluate the effect of exercise on heart rate corrected diastolic time in controls, IDCM with and without LB ...
Optimizing of Heart Failure Medical Therapy after Cardiac
... This study indicates that optimization of treatment with BB and ACEi/ARB is possible after CRT implantation in an unselected cohort of patients with HF, and that adherence to HF medication remains high with sustained mean doses during 4 years of follow-up. Treatment with higher doses of BB and ACEi/ ...
... This study indicates that optimization of treatment with BB and ACEi/ARB is possible after CRT implantation in an unselected cohort of patients with HF, and that adherence to HF medication remains high with sustained mean doses during 4 years of follow-up. Treatment with higher doses of BB and ACEi/ ...
CAR
... Introduction: Cardiac Myxoma is a rare cause of cerebrovascular disease in children. Primary cardiac tumors in children are seldom found and myxoma (14%) is the third common type after rhabdomyomas and fibromas. Case Report: 11 year old male child presented with sudden fall and right hemiplegia. Exa ...
... Introduction: Cardiac Myxoma is a rare cause of cerebrovascular disease in children. Primary cardiac tumors in children are seldom found and myxoma (14%) is the third common type after rhabdomyomas and fibromas. Case Report: 11 year old male child presented with sudden fall and right hemiplegia. Exa ...
Congenital Complete Atrioventricular Block
... the absence of any significant associated congenital heart disease. In a considerable number of patients, however, the clinical findings are highly suggestive of an associated intracardiac left-to-right shunt, specifically a ventricular or atrial septal defect, without being completely diagnostic of ...
... the absence of any significant associated congenital heart disease. In a considerable number of patients, however, the clinical findings are highly suggestive of an associated intracardiac left-to-right shunt, specifically a ventricular or atrial septal defect, without being completely diagnostic of ...
EXERCISE AND THE CARDIOVASCULAR SYSTEM
... List the specific biochemical and cellular adaptations that are made by the body in response to training. Describe and trace the route taken by oxygen molecules as they work through the CV system and are delivered to the working cells. 6. Review the current methods of testing cardiovascular conditio ...
... List the specific biochemical and cellular adaptations that are made by the body in response to training. Describe and trace the route taken by oxygen molecules as they work through the CV system and are delivered to the working cells. 6. Review the current methods of testing cardiovascular conditio ...
Advanced 12 Lead EKG Lecture Worksheet #4
... ____6. Placement of right Precordial leads is identical to the standard Precordial leads except on the right side of the chest. ____7. 0.12 seconds is equal to 120 milliseconds ____8. The axes of leads I, II, and III form an equilateral triangle with the heart at the center. (Einthoven’s triangle). ...
... ____6. Placement of right Precordial leads is identical to the standard Precordial leads except on the right side of the chest. ____7. 0.12 seconds is equal to 120 milliseconds ____8. The axes of leads I, II, and III form an equilateral triangle with the heart at the center. (Einthoven’s triangle). ...
Job Description
... To analyse 24 hour holter monitoring data using digital technology. To correlate data and make decisions based on own interpretation and information within appropriate professional and clinical guidelines. To provide factual reports and take appropriate action to ensure patient safety and treatment ...
... To analyse 24 hour holter monitoring data using digital technology. To correlate data and make decisions based on own interpretation and information within appropriate professional and clinical guidelines. To provide factual reports and take appropriate action to ensure patient safety and treatment ...
Myocarditis
... pumping chambers of the heart, become enlarged, sometimes resulting in congestive heart failure. Myocarditis can cause irregular heartbeats, such as arrhythmias or heart block, in which the pumping of the heart chambers becomes out of synch. It may also lead to Pericarditis - the inflammation of the ...
... pumping chambers of the heart, become enlarged, sometimes resulting in congestive heart failure. Myocarditis can cause irregular heartbeats, such as arrhythmias or heart block, in which the pumping of the heart chambers becomes out of synch. It may also lead to Pericarditis - the inflammation of the ...
Supraventricular Tachycardia and Artial Fibrillation
... Decrease symptoms in 30-60% Randomized clinical trials show no superiority Failure on a single drug therapy can try a combo of two or add one a class IC or class III antiarrhythmic Long term treatment with class IC not recommended, and patents should be referred for catheter ablation ...
... Decrease symptoms in 30-60% Randomized clinical trials show no superiority Failure on a single drug therapy can try a combo of two or add one a class IC or class III antiarrhythmic Long term treatment with class IC not recommended, and patents should be referred for catheter ablation ...
Brevibloc*?(Esmolol HCl)
... • Esmolol compares favorably with verapamil with respect to both efficacy and safety in acutely decreasing ventricular response during atrial fibrillation or flutter. • Conversion to sinus rhythm is significantly more likely with esmolol. ...
... • Esmolol compares favorably with verapamil with respect to both efficacy and safety in acutely decreasing ventricular response during atrial fibrillation or flutter. • Conversion to sinus rhythm is significantly more likely with esmolol. ...
Diastolic Pressure Gradient€Predicts Outcome in€Patients With
... these patients with CKD did not receive warfarin treatment despite having higher stroke risk, probably due to the concomitant higher bleeding risk. Of note, fewer than one-fourth of these dialysis patients (22.9%) were receiving warfarin. In contrast to this study, another recently published study ( ...
... these patients with CKD did not receive warfarin treatment despite having higher stroke risk, probably due to the concomitant higher bleeding risk. Of note, fewer than one-fourth of these dialysis patients (22.9%) were receiving warfarin. In contrast to this study, another recently published study ( ...
Unit2-CardiacVascularSystemInAction
... The cardiovascular system in action 1/Cardiac function and cardiac output 2/ Cardiac cycle 3/ Cardiac conducting system ...
... The cardiovascular system in action 1/Cardiac function and cardiac output 2/ Cardiac cycle 3/ Cardiac conducting system ...
Serum uric acid, NT-ProBNP and hs-CRP as biomarkers in chronic
... pump an adequate blood supply to the tissues. Both Uric Acid (UA) and NT-proBNP was recently established as a prognostic marker for poor outcome in chronic HF. Inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) has also been suggested as cardiovascular risk biomarkers. This st ...
... pump an adequate blood supply to the tissues. Both Uric Acid (UA) and NT-proBNP was recently established as a prognostic marker for poor outcome in chronic HF. Inflammatory markers such as high-sensitivity C-reactive protein (hs-CRP) has also been suggested as cardiovascular risk biomarkers. This st ...
Palpitations - COR Medical Group
... problem with the heart. However, as palpitations can be due to a true cardiac arrhythmia, these symptoms often appropriately prompt a medical evaluation. A cardiac arrhythmia is a condition caused by a problem with the heart's electrical system. These abnormal rhythms may make the heart pump less ef ...
... problem with the heart. However, as palpitations can be due to a true cardiac arrhythmia, these symptoms often appropriately prompt a medical evaluation. A cardiac arrhythmia is a condition caused by a problem with the heart's electrical system. These abnormal rhythms may make the heart pump less ef ...
5- Normal electrocardiogram
... Figure (17): Normal waves of ECG (Ganong's review of medical physiology 2010) ECG leads: The electrocardiograph is a modified galvanometer that measures the difference in action potential between two points. 1- Bipolar limb leads: They record the difference between two limbs. Lead I; between right ...
... Figure (17): Normal waves of ECG (Ganong's review of medical physiology 2010) ECG leads: The electrocardiograph is a modified galvanometer that measures the difference in action potential between two points. 1- Bipolar limb leads: They record the difference between two limbs. Lead I; between right ...
Weekly EMS Drill
... is more accurately a parasympathetic muscarinic receptor site antagonist, meaning it blocks the action of the muscarinic receptor sites in the cardiac arena, reducing cell permeability to potassium ions, therefore not allowing the cell to hyperpolarize. So, again, technically it does NOT “speed up t ...
... is more accurately a parasympathetic muscarinic receptor site antagonist, meaning it blocks the action of the muscarinic receptor sites in the cardiac arena, reducing cell permeability to potassium ions, therefore not allowing the cell to hyperpolarize. So, again, technically it does NOT “speed up t ...
Place: Bellary
... to the cardiac valves without an inflammatory reaction. It is estimated that this condition occurs in 3% to 5% of AIDS patients10. It usually occurs in patients older than 50 years. Marantic endocarditis is known to be associated with malignant neoplasms, hypercoagulable states and chronic wasting d ...
... to the cardiac valves without an inflammatory reaction. It is estimated that this condition occurs in 3% to 5% of AIDS patients10. It usually occurs in patients older than 50 years. Marantic endocarditis is known to be associated with malignant neoplasms, hypercoagulable states and chronic wasting d ...
Learning Resources - San Jose State University School of Nursing
... to touch, purulent drainage. Rationale: Infection may be present 15. What will you include in your long-term teaching? ...
... to touch, purulent drainage. Rationale: Infection may be present 15. What will you include in your long-term teaching? ...
ATRIAL FIBRILLATION CARDIOVERSION FOLLOWING
... His blood pressure was 130/80 mmHg , pulse above 125/min, pulse oximeter showed 98% oxygenation. His BMI was 29.2 kg/m2, body temperature 36.7°C. ECG showed atrial fibrillation with an average ventricular response of 107 bpm. He had a left electrical axis and left anterior fascicular block. There we ...
... His blood pressure was 130/80 mmHg , pulse above 125/min, pulse oximeter showed 98% oxygenation. His BMI was 29.2 kg/m2, body temperature 36.7°C. ECG showed atrial fibrillation with an average ventricular response of 107 bpm. He had a left electrical axis and left anterior fascicular block. There we ...
211 Atrial Dysrhythmias notes
... Adjusted for patient's body surface area (BSA) The Conduction System of the Heart Intrinsic conduction o Complex electrical circuit that perpetuates cardiac cycle Sinoatrial (SA) node Atrioventricular (AV) node Cardiac rate and rhythm assessment Tachycardia or bradycardia Dysrhythmia S ...
... Adjusted for patient's body surface area (BSA) The Conduction System of the Heart Intrinsic conduction o Complex electrical circuit that perpetuates cardiac cycle Sinoatrial (SA) node Atrioventricular (AV) node Cardiac rate and rhythm assessment Tachycardia or bradycardia Dysrhythmia S ...
Chapter 20: The Cardiovascular System: The Heart
... Conduction System of Heart Cardiac muscle cells are autorhythmic cells because they are self-excitable. They repeatedly generate spontaneous action potentials that then trigger heart contractions. (Fig 20.10) The autonomic nervous system and hormones, such as epinephrine, do modify the heartbeat (in ...
... Conduction System of Heart Cardiac muscle cells are autorhythmic cells because they are self-excitable. They repeatedly generate spontaneous action potentials that then trigger heart contractions. (Fig 20.10) The autonomic nervous system and hormones, such as epinephrine, do modify the heartbeat (in ...
Immunohistochemical analysis
... Sudden Cardiac Death (SCD) is usually unexpected death from arrhythmia or acute ventricular failure. This can happen to an individual with or without known pre-existing heart disease. Cardiac arrest occurs after a while when the heart’s output is absent or inadequate and is followed by circulatory c ...
... Sudden Cardiac Death (SCD) is usually unexpected death from arrhythmia or acute ventricular failure. This can happen to an individual with or without known pre-existing heart disease. Cardiac arrest occurs after a while when the heart’s output is absent or inadequate and is followed by circulatory c ...
Cardiac contractility modulation
.jpg?width=300)
Cardiac contractility modulation (CCM) is a treatment for patients with moderate to severe left ventricular systolic heart failure (NYHA class II–IV). The short- and long-term use of this therapy enhances both the strength of ventricular contraction and the heart’s pumping capacity. The CCM mechanism is based on stimulation of the cardiac muscle by non-excitatory electrical signals (NES). CCM treatment is delivered by a pacemaker-like device that applies the NES, adjusted to and synchronized with the electrical action in the cardiac cycle.In CCM therapy, electrical stimulation is applied to the cardiac muscle during the absolute refractory period. In this phase of the cardiac cycle, electrical signals cannot trigger new cardiac muscle contractions, hence this type of stimulation is known as a non-excitatory stimulation. However, the electrical CCM signals increase the influx of calcium ions into the cardiac muscle cells (cardiomyocytes). In contrast to other electrical stimulation treatments for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), CCM does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, CCM is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO2). This may be explained by the beneficial effect CCM has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based treatment options in heart failure in 2013 concluded that CCM treatment is safe, that it is generally beneficial to patients and that CCM treatment increases the exercise tolerance (ET) and quality of life (QoL) of patients. Furthermore, preliminary long-term survival data shows that CCM is associated with lower long-term mortality in heart failure patients when compared with expected rates among similar patients not treated with CCM.